Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy.
Filippova A, Charles J, Epaulard O, Germi R, Persoons V, Templier I, Leccia MT, Dreno B, Malova I, Morand P, Lupo J.
Filippova A, et al. Among authors: morand p.
Cytotherapy. 2018 Apr;20(4):521-523. doi: 10.1016/j.jcyt.2017.12.006. Epub 2018 Feb 9.
Cytotherapy. 2018.
PMID: 29434005